AFP launches online course to tackle climate misinformation
Leading global news agency AFP releases an online training course to equip journalists and journalism students with tools and techniques to tackle climate misinformation.
Jerusalem (AFP) | 08/07/2025 - 05:43:08 | Five Israeli soldiers killed in Gaza: military
Bangkok (AFP) | 08/07/2025 - 05:18:48 | Thai acting PM says wants 'better deal' than Trump threatened tariff
Washington (AFP) | 08/07/2025 - 01:55:12 | US to send 'more weapons' to Ukraine: Trump
Washington (AFP) | 08/07/2025 - 01:41:15 | Trump says Hamas 'want to have that ceasefire' in Gaza
Washington (AFP) | 08/07/2025 - 01:35:59 | Netanyahu says has nominated Trump for Nobel Peace Prize
Hunt, Texas (AFP) | 08/07/2025 - 00:22:48 | Deaths from central Texas flooding surpass 100, officials say
Nairobi (AFP) | 07/07/2025 - 21:20:10 | 567 people arrested during Kenya protests: police statement
Tehran (AFP) | 07/07/2025 - 20:00:44 | Iran says death toll from war with Israel reaches 1,060: state TV
Washington (AFP) | 07/07/2025 - 19:46:38 | White House says ending Gaza war 'utmost' priority for Trump
Washington (AFP) | 07/07/2025 - 19:45:59 | Trump to sign order delaying tariff deadline to Aug 1: W.House
Leading global news agency AFP releases an online training course to equip journalists and journalism students with tools and techniques to tackle climate misinformation.
Agence France-Presse (AFP) is pleased to announce that Michael Mainville has taken up his role as the new Asia-Pacific Regional Director as of April 3rd, 2023.
After training with journalists from Agence France-Presse and the Austrian news agency APA, Ukraine’s largest news agency Ukrinform has started writing its own fact-check articles in an effort to confront a wave of war-related disinformation.
It is the first major Ukrainian media outlet to be trained in fact-checking, a crucial step as Russia’s conflict in Ukraine has entered its second year.
AFP and the Web3 art platform LaCollection have announced that a second collection of digital editions (NFT) of press photos from the agency's archives will go on sale in April 2023.
The widest alliance between German-speaking digital investigators and researchers, known as GADMO, has launched its website in a further step in the battle against online falsehoods.
Exactly one year ago, AFP reported live from Kyiv’s central Maidan Square that the Russian offensive had begun against Ukraine. Since then, the agency has deployed unprecedented resources to cover this war in the heart of Europe and its consequences for the daily lives of Ukrainians, Russians and people in the rest of the world.
Germany’s respected Grimme institute has just published a comparative analysis of fact-checking organisations in the country, which highlights the quality of Agence France-Presse’s digital verification production.
Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry’s first fully-transparent machine learning platform for clinical real-time PCR diagnostics – demonstrating exactly how each result was achieved, a first for molecular-testing machine learning. The technology is backed by over 15 years of experience and millions of successfully processed samples with >9...
Reply, a global systems integrator and technology consulting firm, introduces “App to the Future” an immersive “AI-Scape Room” an immersive escape room experience powered by Microsoft Copilot, Azure AI, and Power Platform, designed to explore the full potential of AI and low-code tools in a unique and engaging way. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513072546/en/The experience builds on Reply’s AI-Scape Room focused on...
GSK plc (LSE/NYSE: GSK) and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases, today announced that they have entered into an agreement under which GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Efimosfermin is a phase III-ready, potential best-in-class, investigational specialty medicine to treat and prevent progression of steatotic liver disease (SLD). Under the agre...